These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1718615

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. In the search for new anticancer drugs XI. Anticancer activity of nitroxyl labeled phosphoric N,N;N',N';N",N"-tris[1,2-ethanediyl]triamide(TEPA) and phosphorothioic N,N;N',N';N",N"-tris[1,2-ethanediyl]triamide(thio-TEPA) derivatives.
    Sosnovsky G, Li SW.
    Cancer Lett; 1985 Jan; 25(3):255-60. PubMed ID: 2578867
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Measurement of ThioTEPA and Its Metabolite TEPA in Plasma and Cerebrospinal Fluid by Turbulent Flow Chromatography-Tandem Mass Spectrometry.
    Schofield RC, Scordo M, Shah G, Carlow DC.
    Methods Mol Biol; 2024 Jan; 2737():423-433. PubMed ID: 38036843
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Thiono compounds. 4. In vitro mutagenic and antineoplastic activity of TEPA and thio-TEPA.
    Breau AP, Field L, Mitchell WM.
    Cell Biol Toxicol; 1984 Oct; 1(1):21-30. PubMed ID: 6086064
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid.
    O'Dwyer PJ, LaCreta F, Nash S, Tinsley PW, Schilder R, Clapper ML, Tew KD, Panting L, Litwin S, Comis RL.
    Cancer Res; 1991 Nov 15; 51(22):6059-65. PubMed ID: 1933869
    [Abstract] [Full Text] [Related]

  • 32. The effect of pretreatment with thio-TEPA and cytosine arabinoside on megakaryocytopoiesis in rats given a sublethal dose of thio-TEPA.
    Tanum G, Sønstevold A, Engeset A.
    Blut; 1987 Jan 15; 54(1):33-41. PubMed ID: 3099865
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In the search for new anticancer drugs. 26. A comparison of anticancer activities of several TEPA, thio-TEPA, Seleno-TEPA, and azetidine analogs, including congeners containing an aminoxyl moiety.
    Sosnovsky G, Lukszo J, Konieczny M, Purgstaller K, Laib F.
    J Pharm Sci; 1994 Jul 15; 83(7):982-8. PubMed ID: 7525922
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Dose escalation of N,N',N"-triethylenethiophosphoramide combined with pentoxifylline for advanced breast cancer.
    Shapiro CL, Dezube BJ, Tretyakov O, Wright J, Cap B, Henderson IC, Hayes DF.
    Clin Cancer Res; 1995 Aug 15; 1(8):791-6. PubMed ID: 9816047
    [Abstract] [Full Text] [Related]

  • 39. The binding of thio-TEPA in human serum and to isolated serum protein fractions.
    Hagen B, Nilsen OG.
    Cancer Chemother Pharmacol; 1987 Aug 15; 20(4):319-23. PubMed ID: 3121202
    [Abstract] [Full Text] [Related]

  • 40. Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma.
    Hagen B, Walseth F, Walstad RA, Iversen T, Nilsen OG.
    Cancer Chemother Pharmacol; 1987 Aug 15; 19(2):143-8. PubMed ID: 3105905
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.